Tianyu Bio's 2026 interim net loss of 54.3763 million yuan, swinging from profit to loss

Earnings
โดย Jiemian·Read original
Summary · why it matters

Tianyu Bio released its 2026 interim report. Total operating revenue was 351 million yuan, down 14.95% year on year. Net profit attributable to the parent company was negative 54.3763 million yuan, a decrease of 65.1943 million yuan from the same period last year, a decline of 602.65%, swinging from profit to loss. Net cash flow from operating activities was negative 5.2863 million yuan, down 105.89% year on year. The company's asset-liability ratio rose to 80.99%, gross margin was negative 0.97%, return on equity was negative 16.05%, and diluted earnings per share was negative 0.19 yuan.

Impact on stocks 1

Others · 1 stocks